Fahimeh Attarian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fahimeh Attarian has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Seyed Alireza Javadinia
Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
3 shared publications - Danial Fazilat-Panah
Assistant Professor of Radiation Oncology, Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran
2 shared publications Hadi Harati
Pediatric Gastroenterology and Hepatology Research Center, Zabol University of Medical Sciences, Zabol, Iran
2 shared publications- Ali Kermani
Electrical & Computer Engineering Department, University of Science & Technology of Mazandaran, Behshahr, Iran
1 shared publication - Ali Shabestani Monfared
Babol University of Medical Sciences
1 shared publication Azita Ganji
Department of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- 5 March 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101  (5) , 541-548
Effects of low dose rate radiotherapy on pain relief, performance score, and quality of life in patients with knee osteoarthritis; a double-blind sham-controlled randomized clinical trial
Knee osteoarthritis (OA) is a prevalent chronic condition characterized by progressive damage to the articular cartilage, resulting in chronic pain, swelling, and reduced range of motion with a range of prevalence of 10-40%. This study aims to investigate the efficacy of low-dose radiation as a local treatment option for knee OA symptoms. In this prospective study, patients with confirmed OA and older than 65 years were randomly assigned to treatment and control groups. The protocol plan IRCT20160706028815N6 was registered in Iranian registry of clinical trials system. The treatment group received 3 Gy radiation over six fractions, while the control group continued routine treatment without radiation. The pain intensity and functional levels were assessed at pretreatment and each month following completion of therapy for six consecutive months by Visual Analog Scale (VAS) and the Lysholm 100-point Scale, respectively. Analgesic medication usage and performance status (PS) were also assessed. The mean age of the patients was 77 years (range 72-89). All variables including VAS pain score, Lysholm scale, PS and analgesic consumption were improved following radiation from first month to the end of assessments (p value <0.01). Results showed significant pain score improvements and enhanced joint function with no adverse effects. Findings were compared with previous studies, revealing mixed conclusions on low dose radiation therapy (LDRT) efficacy. Mechanistic hypotheses suggest LDRT may modulate inflammatory pathways. The study suggests LDRT at 3 Gy could benefit knee osteoarthritis patients and calls for further research on mechanisms of action in early-stage osteoarthritis.
- 5 March 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101  (5) , 541-548
Effects of low dose rate radiotherapy on pain relief, performance score, and quality of life in patients with knee osteoarthritis; a double-blind sham-controlled randomized clinical trial
Knee osteoarthritis (OA) is a prevalent chronic condition characterized by progressive damage to the articular cartilage, resulting in chronic pain, swelling, and reduced range of motion with a range of prevalence of 10-40%. This study aims to investigate the efficacy of low-dose radiation as a local treatment option for knee OA symptoms. In this prospective study, patients with confirmed OA and older than 65 years were randomly assigned to treatment and control groups. The protocol plan IRCT20160706028815N6 was registered in Iranian registry of clinical trials system. The treatment group received 3 Gy radiation over six fractions, while the control group continued routine treatment without radiation. The pain intensity and functional levels were assessed at pretreatment and each month following completion of therapy for six consecutive months by Visual Analog Scale (VAS) and the Lysholm 100-point Scale, respectively. Analgesic medication usage and performance status (PS) were also assessed. The mean age of the patients was 77 years (range 72-89). All variables including VAS pain score, Lysholm scale, PS and analgesic consumption were improved following radiation from first month to the end of assessments (p value <0.01). Results showed significant pain score improvements and enhanced joint function with no adverse effects. Findings were compared with previous studies, revealing mixed conclusions on low dose radiation therapy (LDRT) efficacy. Mechanistic hypotheses suggest LDRT may modulate inflammatory pathways. The study suggests LDRT at 3 Gy could benefit knee osteoarthritis patients and calls for further research on mechanisms of action in early-stage osteoarthritis.
- Open Access
- 11 May 2023
- Published by Springer Nature in Research Square
Predictive and preventive Factors related to of head lice infestations among teenage girls student: Application of Health Belief Model
Background: Despite of improving public health, head lice infestations has remained as an important health issue among all society in worldwide. Head lice infestations are common in areas with high population density and associated with low socioeconomic status and health literacy. This study aimed to evaluate the preventive behaviors related to pediculosis based on the Health Belief Model (HBM) in teenage girl students. Methods & Material: This cross-sectional survey was performed on 200 teenage girl students that randomly selected from 4 schools in different geographical areas in Torbat Heydaryeh city-Iran. A structured questionnaire was designed to collect the data on socio-demographic characteristics, health belief model constructs and pediculosis-related behaviors. This data was descripted and analyzed by two-sample t-test, Pearson's correlation coefficient and regression analysis using SPSS 22. Result: The overall percentage of head lice infestations was 4.1% and 9.5% of participations had experience of head lice infestations in the 3 past months. Itching reported in 30% of infected students (p < 0.001). Head lice infestations strongly predicted with itching on a scalp (OR = 73.2, 95% CI 8.23, 652.2), and the main protective factor for Head lice infestations was adopt of preventive behavior (OR = 0.68, 95% CI 0.47, 0.97), also the preventive behavior (according to HBM model) were explained by Perceived barriers, self-efficiency and predisposing factors (5.7%, 5.6% and 7.8%) respectively. Conclusion: It seems that should providing necessary trainings with an emphasis on recognizing symptoms of disease and promoting preventive behavior by reinforcing predisposing factors, perceived barriers and self-efficacy in students.
- 11 May 2023
- Published by Springer Nature in Research Square
Open AccessPredictive and preventive Factors related to of head lice infestations among teenage girls student: Application of Health Belief Model
Background: Despite of improving public health, head lice infestations has remained as an important health issue among all society in worldwide. Head lice infestations are common in areas with high population density and associated with low socioeconomic status and health literacy. This study aimed to evaluate the preventive behaviors related to pediculosis based on the Health Belief Model (HBM) in teenage girl students. Methods & Material: This cross-sectional survey was performed on 200 teenage girl students that randomly selected from 4 schools in different geographical areas in Torbat Heydaryeh city-Iran. A structured questionnaire was designed to collect the data on socio-demographic characteristics, health belief model constructs and pediculosis-related behaviors. This data was descripted and analyzed by two-sample t-test, Pearson's correlation coefficient and regression analysis using SPSS 22. Result: The overall percentage of head lice infestations was 4.1% and 9.5% of participations had experience of head lice infestations in the 3 past months. Itching reported in 30% of infected students (p < 0.001). Head lice infestations strongly predicted with itching on a scalp (OR = 73.2, 95% CI 8.23, 652.2), and the main protective factor for Head lice infestations was adopt of preventive behavior (OR = 0.68, 95% CI 0.47, 0.97), also the preventive behavior (according to HBM model) were explained by Perceived barriers, self-efficiency and predisposing factors (5.7%, 5.6% and 7.8%) respectively. Conclusion: It seems that should providing necessary trainings with an emphasis on recognizing symptoms of disease and promoting preventive behavior by reinforcing predisposing factors, perceived barriers and self-efficacy in students.
- 30 May 2022
- Published by Taylor & Francis in Cancer Investigation
- Vol. 40  (6) , 505-515
Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
To determine the clinical characteristics and outcomes of COVID-19 in a large cohort of new cancer patients referred to an oncology clinic in the north of Iran.During the 20-month COVID-19 pandemic...
- 30 May 2022
- Published by Taylor & Francis in Cancer Investigation
- Vol. 40  (6) , 505-515
Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
To determine the clinical characteristics and outcomes of COVID-19 in a large cohort of new cancer patients referred to an oncology clinic in the north of Iran.During the 20-month COVID-19 pandemic...
- Open Access
- 2 May 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 860238
COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
Background: Data on the efficacy and safety of COVID-19 vaccines in patients with malignancy are immature. In this paper, we assessed the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome and severity of COVID-19 infection and side effects following COVID-19 vaccination as the secondary outcomes.Methods: A systematic review with meta-analysis was performed. Searches were conducted in electronic websites, databases, and journals, including Scopus, PubMed, Embase, and Web of Science from January 01, 2019, to November 30, 2021. Studies reporting data on the safety and efficacy of COVID vaccine in cancer patients using any human samples were included. The risk of bias was assessed using the NEWCASTLE-OTTAWA scale in the included studies.Results: A total of 724 articles were identified from databases, out of which 201 articles were duplicates and were discarded. Subsequently, 454 articles were excluded through initial screening of the titles and abstracts. Moreover, 41 studies did not report the precise seroconversion rate either based on the type of cancer or after injection of a second dose of COVID vaccine. Finally, 28 articles met all the inclusion criteria and were included in this systematic review. The overall seroconversion rates after receiving a second dose of COVID-19 vaccine, based on type of cancer were 88% (95% CI, 81%-92%) and 70% (95% CI, 60%-79%) in patients with solid tumors and hematologic malignancies, respectively.Conclusion: Overall, we conclude that vaccination against COVID-19 in patients with active malignancies using activated and inactivated vaccines is a safe and tolerable procedure that is also accompanied by a high efficacy.
- 2 May 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 860238
Open AccessCOVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
Background: Data on the efficacy and safety of COVID-19 vaccines in patients with malignancy are immature. In this paper, we assessed the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome and severity of COVID-19 infection and side effects following COVID-19 vaccination as the secondary outcomes.Methods: A systematic review with meta-analysis was performed. Searches were conducted in electronic websites, databases, and journals, including Scopus, PubMed, Embase, and Web of Science from January 01, 2019, to November 30, 2021. Studies reporting data on the safety and efficacy of COVID vaccine in cancer patients using any human samples were included. The risk of bias was assessed using the NEWCASTLE-OTTAWA scale in the included studies.Results: A total of 724 articles were identified from databases, out of which 201 articles were duplicates and were discarded. Subsequently, 454 articles were excluded through initial screening of the titles and abstracts. Moreover, 41 studies did not report the precise seroconversion rate either based on the type of cancer or after injection of a second dose of COVID vaccine. Finally, 28 articles met all the inclusion criteria and were included in this systematic review. The overall seroconversion rates after receiving a second dose of COVID-19 vaccine, based on type of cancer were 88% (95% CI, 81%-92%) and 70% (95% CI, 60%-79%) in patients with solid tumors and hematologic malignancies, respectively.Conclusion: Overall, we conclude that vaccination against COVID-19 in patients with active malignancies using activated and inactivated vaccines is a safe and tolerable procedure that is also accompanied by a high efficacy.
- Open Access
- 26 December 2021
- Published by Naba'a Al-Hayat Foundation for Medical Sciences and Health Care in Journal of Contemporary Medical Sciences
- Vol. 7  (6) , 340-345
Common Clinical Symptoms and Concomitant Disease in Celiac Patients – A Large Cohort Study in the North-East of Iran
Objectives: This study aimed to provides an overview of large cohort focusing in different clinical symptoms and concomitant disease in CD patients. Methods: Out of total 1,164 cases, 78.86% of cases were adults (mean age 29.67 ± 15.94) and sex ratio (f/m) was 2.40. Evaluated clinical characteristics included BMI, Marsh, TGA-IgA titer, main symptoms and concomitant disease. Results: 96.86% of CD cases were seropositive anmore than 88% of patients had villous atrophy that 48.89% of them were type c. Dyspepsia 35.23%, diarrhea 18.52%, were main CD clinical symptoms. The common concomitant diseases were including nervous problems 57.43%, anemia 54.25%, osteopenia 28.23% and skin disease 23.54%. Conclusion: the classic type is common type of CD in northeast Iran. Dyspepsia and diarrhea main clinical symptoms in these patients, consequence we recommended to screening for CD in cases whiteout classic symptoms (such as dyspepsia). Also recommended to screening for concomitant disease such as nervous problems, bon disease and anemia in female CD patients in first visit.
- 26 December 2021
- Published by Naba'a Al-Hayat Foundation for Medical Sciences and Health Care in Journal of Contemporary Medical Sciences
- Vol. 7  (6) , 340-345
Open AccessCommon Clinical Symptoms and Concomitant Disease in Celiac Patients – A Large Cohort Study in the North-East of Iran
Objectives: This study aimed to provides an overview of large cohort focusing in different clinical symptoms and concomitant disease in CD patients. Methods: Out of total 1,164 cases, 78.86% of cases were adults (mean age 29.67 ± 15.94) and sex ratio (f/m) was 2.40. Evaluated clinical characteristics included BMI, Marsh, TGA-IgA titer, main symptoms and concomitant disease. Results: 96.86% of CD cases were seropositive anmore than 88% of patients had villous atrophy that 48.89% of them were type c. Dyspepsia 35.23%, diarrhea 18.52%, were main CD clinical symptoms. The common concomitant diseases were including nervous problems 57.43%, anemia 54.25%, osteopenia 28.23% and skin disease 23.54%. Conclusion: the classic type is common type of CD in northeast Iran. Dyspepsia and diarrhea main clinical symptoms in these patients, consequence we recommended to screening for CD in cases whiteout classic symptoms (such as dyspepsia). Also recommended to screening for concomitant disease such as nervous problems, bon disease and anemia in female CD patients in first visit.
- Open Access
- 26 September 2021
- Published by Springer Nature in BMC Research Notes
- Vol. 14  (1) , 1-6
Factors predicting readmission in patients with COVID-19
Objective: COVID-19 has been introduced by the World Health Organization as a health emergency worldwide. Up to 9% of the patients with COVID-19 may be readmitted by 2 months after discharge. This study aimed to estimate the readmission rate and identify main risk factors for readmission in these patients. In this prospective study, 416 discharged COVID patients followed up with a minimum 1 month and the readmission rate was recorded. Evaluated characteristics included time of readmission, age and sex, main symptoms of disease, result of computed tomography scan, reverse transcription polymerase chain reaction test and treatment modalities. Results: Regarding readmission, 51 patients of 416 discharged patients, was readmitted during the study period. The rate of readmission for 30 and 60 days after discharge was 7.6% and 8.1%, respectively. The median age of the readmitted patients was 67 years (IQR: 53–78). About 65% of readmitted patients had underlying disease. The most significant factor in readmission rate was related to the site of lung involvement (OR > 4). Age over 60 years, underlying disease especially diabetes (OR = 3.43), high creatinine level (≥ to 1.2 mg/dl) (OR = 2.15) were the most important predictors of readmission.
- 26 September 2021
- Published by Springer Nature in BMC Research Notes
- Vol. 14  (1) , 1-6
Open AccessFactors predicting readmission in patients with COVID-19
Objective: COVID-19 has been introduced by the World Health Organization as a health emergency worldwide. Up to 9% of the patients with COVID-19 may be readmitted by 2 months after discharge. This study aimed to estimate the readmission rate and identify main risk factors for readmission in these patients. In this prospective study, 416 discharged COVID patients followed up with a minimum 1 month and the readmission rate was recorded. Evaluated characteristics included time of readmission, age and sex, main symptoms of disease, result of computed tomography scan, reverse transcription polymerase chain reaction test and treatment modalities. Results: Regarding readmission, 51 patients of 416 discharged patients, was readmitted during the study period. The rate of readmission for 30 and 60 days after discharge was 7.6% and 8.1%, respectively. The median age of the readmitted patients was 67 years (IQR: 53–78). About 65% of readmitted patients had underlying disease. The most significant factor in readmission rate was related to the site of lung involvement (OR > 4). Age over 60 years, underlying disease especially diabetes (OR = 3.43), high creatinine level (≥ to 1.2 mg/dl) (OR = 2.15) were the most important predictors of readmission.
- Open Access
- 25 June 2021
- Published by Springer Nature in Research Square
Risk Factors for Readmission in the Patients with COVID-19 Admitted to Hospital
Objective: COVID-19 has been introduced by the World Health Organization as a health emergency worldwide. Although more than 5% of the patients with COVID-19 require hospitalization, there are still no clear guidelines on patients' discharge time and factors influencing post-discharge outcomes. This study aimed to determine risk factors for readmission in the patients with COVID-19 admitted to hospital. In this prospective study, 416 discharged patients with a minimum follow-up of one month and the need for readmission were recorded. Evaluated characteristics included age, gender, CT scan, RT-PCR test and treatment modalities. After describing the data, any relationship between the patients' characteristics and readmission was assessed and predictive factors of readmission risk were estimated using regression model. The data were analyzed through STATA and P value less than of 0.05 was considered significant.Results: Regarding readmission, 51 patients were readmitted during the study period. The median follow-up time was 20 days (IQR: 7-120) and the mean follow-up time was 61±11.2 days. The mean duration of first hospitalization was 5.5 days and the rate of readmission of the patients between 30 and 60 days after discharge was 7.6% and 8.1%, respectively. The median age of these patients was 67 years (IQR: 53-78). About 65% of readmitted patients had underlying disease. The difference in readmission time was based on blood creatinine level and lung involvement. The odds ratio of readmission in the patients with abnormal creatinine levels (higher and equal to 1.2 mg/dl) and diabetes was equal to 2.15 and 3.43, respectively. Also, the odds ratio of readmission in the patients with basal lung involvement was 4.16. The highest readmission rate was 30 days after discharge. Age over 60 years, underlying disease especially diabetes, high creatinine level and lung involvement were the most important predictors of readmission in the patients with COVID-19.
- 25 June 2021
- Published by Springer Nature in Research Square
Open AccessRisk Factors for Readmission in the Patients with COVID-19 Admitted to Hospital
Objective: COVID-19 has been introduced by the World Health Organization as a health emergency worldwide. Although more than 5% of the patients with COVID-19 require hospitalization, there are still no clear guidelines on patients' discharge time and factors influencing post-discharge outcomes. This study aimed to determine risk factors for readmission in the patients with COVID-19 admitted to hospital. In this prospective study, 416 discharged patients with a minimum follow-up of one month and the need for readmission were recorded. Evaluated characteristics included age, gender, CT scan, RT-PCR test and treatment modalities. After describing the data, any relationship between the patients' characteristics and readmission was assessed and predictive factors of readmission risk were estimated using regression model. The data were analyzed through STATA and P value less than of 0.05 was considered significant.Results: Regarding readmission, 51 patients were readmitted during the study period. The median follow-up time was 20 days (IQR: 7-120) and the mean follow-up time was 61±11.2 days. The mean duration of first hospitalization was 5.5 days and the rate of readmission of the patients between 30 and 60 days after discharge was 7.6% and 8.1%, respectively. The median age of these patients was 67 years (IQR: 53-78). About 65% of readmitted patients had underlying disease. The difference in readmission time was based on blood creatinine level and lung involvement. The odds ratio of readmission in the patients with abnormal creatinine levels (higher and equal to 1.2 mg/dl) and diabetes was equal to 2.15 and 3.43, respectively. Also, the odds ratio of readmission in the patients with basal lung involvement was 4.16. The highest readmission rate was 30 days after discharge. Age over 60 years, underlying disease especially diabetes, high creatinine level and lung involvement were the most important predictors of readmission in the patients with COVID-19.
- Open Access
- 30 March 2021
- Published by Brieflands in International Journal of Cancer Management
- Vol. 14  (3)
Predictive Value of Lymph Node Ratio in Patients with Pancreatic Cancer Treated with Pancreatoduodenectomy
Background: Recently, the predictive value of lymph node ratio (LNR, the ratio of metastatic lymph nodes to total examined lymph nodes) has been evaluated in patients with gastrointestinal malignancies, including pancreatic cancer. However, there is not enough evidence about the prognostic value of this factor. Objectives: We aimed at determining the value of LNR in predicting the survival of patients who have undergone the Whipple procedure. Methods: This cohort study was performed on 96 patients with pancreatic cancer undergoing the Whipple procedure during 2014 - 2019. Demographic, clinical, and pathological data of the patients were extracted from their records and patients' survival status was determined through follow-up. LNR and its effect on survival was calculated using the Cox model. Results: Of the 96 eligible patients, 51 (53.13%) were men. The mean age of the patients was 57.1 ± 14.1 (range: 19 - 82) years. The median total lymph nodes examined was 7 (range: 1 - 27), and no metastatic lymph nodes were found in 57 (59.37%) patients. The median involved lymph nodes and LNR were 2 and 0.17, respectively. Patients with LNR > 0.20 had the lowest 1 and 3-year survival rates. Age (P = 0.04), surgical radial margin (P = 0.001), lymph node status (N0, N1) (P = 0.01), and LNR (P = 0.01) were the most important prognostic factors for survival. Conclusions: LNR is a valuable indicator that can be used in patients with lymph node involvement as a prognostic factor for poor survival after the Whipple procedure. The lowest 1, 3, and 5-year survival rates were seen in patients with LNR > 0.20.
- 30 March 2021
- Published by Brieflands in International Journal of Cancer Management
- Vol. 14  (3)
Open AccessPredictive Value of Lymph Node Ratio in Patients with Pancreatic Cancer Treated with Pancreatoduodenectomy
Background: Recently, the predictive value of lymph node ratio (LNR, the ratio of metastatic lymph nodes to total examined lymph nodes) has been evaluated in patients with gastrointestinal malignancies, including pancreatic cancer. However, there is not enough evidence about the prognostic value of this factor. Objectives: We aimed at determining the value of LNR in predicting the survival of patients who have undergone the Whipple procedure. Methods: This cohort study was performed on 96 patients with pancreatic cancer undergoing the Whipple procedure during 2014 - 2019. Demographic, clinical, and pathological data of the patients were extracted from their records and patients' survival status was determined through follow-up. LNR and its effect on survival was calculated using the Cox model. Results: Of the 96 eligible patients, 51 (53.13%) were men. The mean age of the patients was 57.1 ± 14.1 (range: 19 - 82) years. The median total lymph nodes examined was 7 (range: 1 - 27), and no metastatic lymph nodes were found in 57 (59.37%) patients. The median involved lymph nodes and LNR were 2 and 0.17, respectively. Patients with LNR > 0.20 had the lowest 1 and 3-year survival rates. Age (P = 0.04), surgical radial margin (P = 0.001), lymph node status (N0, N1) (P = 0.01), and LNR (P = 0.01) were the most important prognostic factors for survival. Conclusions: LNR is a valuable indicator that can be used in patients with lymph node involvement as a prognostic factor for poor survival after the Whipple procedure. The lowest 1, 3, and 5-year survival rates were seen in patients with LNR > 0.20.
- Open Access
- 9 September 2020
- Vol. 34, 117
Assessment of intelligence quotient score in children at the age of six with suspected congenital hypothyroidism: A retrospective cohort study
Background: The clinical suspicion of Congenital Hypothyroidism (CH) is identified by abnormal results in the first test of Thyroid Stimulating Hormone (TSH) (5-9.9 mIU/L), and normal results in re-test (TSH<4 mIU/L). The CH has a contribution to physical and mental health. This study aimed to determine the Intelligence Quotient (IQ) score in children with suspected congenital hypothyroidism.
- 9 September 2020
- Vol. 34, 117
Open AccessAssessment of intelligence quotient score in children at the age of six with suspected congenital hypothyroidism: A retrospective cohort study
Background: The clinical suspicion of Congenital Hypothyroidism (CH) is identified by abnormal results in the first test of Thyroid Stimulating Hormone (TSH) (5-9.9 mIU/L), and normal results in re-test (TSH<4 mIU/L). The CH has a contribution to physical and mental health. This study aimed to determine the Intelligence Quotient (IQ) score in children with suspected congenital hypothyroidism.